big changes in treating chronic hepatitis C with two new oral antivirals, Galexos (simeprevir) and Sovaldi (sofosbuvir)

You'll see big changes in treating chronic hepatitis C with two new oral antivirals, Galexos (simeprevir) and Sovaldi (sofosbuvir).

Most patients currently get "triple therapy"...with peginterferon, ribavirin, plus an oral protease inhibitor (Incivek, Victrelis).

Now new drugs...including some in the pipeline...will make treatment easier, more effective, and better tolerated.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote